Structural and functional characterization of a single-chain peptide - MHC molecule that modulates both naive and activated CD8 + T cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 33, 2011, Pages 13682-13687

  Samanta, Dibyendu ^a   Mukherjee, Gayatri ^a   Ramagopal, Udupi A ^a   Chaparro, Rodolfo J ^a   Nathenson, Stanley G ^a   DiLorenzo, Teresa P ^a   Almo, Steven C ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GLUCOSE 6 PHOSPHATASE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TETRAMER;

ANIMAL CELL; ARTICLE; AUTOIMMUNE DISEASE; CD8+ T LYMPHOCYTE; COVALENT BOND; CYTOTOXIC T LYMPHOCYTE; IMMUNOMODULATION; INTERFERON PRODUCTION; MALE; MOUSE; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; T LYMPHOCYTE ACTIVATION; X RAY DIFFRACTION;

ANIMALS; AUTOANTIGENS; AUTOIMMUNE DISEASES; CD8-POSITIVE T-LYMPHOCYTES; CELL DEATH; DIABETES MELLITUS, TYPE 1; GLUCOSE-6-PHOSPHATASE; HISTOCOMPATIBILITY ANTIGENS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED NOD; MICE, TRANSGENIC; PEPTIDE FRAGMENTS; PROTEIN MULTIMERIZATION;

MUS;

EID: 80051992049     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1110971108     Document Type: Article

References (48)

1. + T cells in autoimmunity. Curr Opin Immunol 17:624-631.
2. Angelov G.S., et al. (2006) Soluble MHC-peptide complexes containing long rigid linkers abolish CTL-mediated cytotoxicity. J Immunol 176:3356-3365. (Pubitemid 43363982)
3. + CTL. J Immunol 174:6809-6819.
4. Dal Porto J., et al. (1993) A soluble divalent class I major histocompatibility complex molecule inhibits alloreactive T cells at nanomolar concentrations. Proc Natl Acad Sci USA 90:6671-6675.
5. O'Herrin S.M., et al. (2001) Antigen-specific blockade of T cells in vivo using dimeric MHC peptide. J Immunol 167:2555-2560. (Pubitemid 32768882)
6. Boise L.H., et al. (1995) CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity 3:87-98.
7. Gimmi C.D., Freeman G.J., Gribben J.G., Gray G., Nadler L.M. (1993) Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. Proc Natl Acad Sci USA 90:6586-6590. (Pubitemid 23207258)
8. Harding F.A., McArthur J.G., Gross J.A., Raulet D.H., Allison J.P. (1992) CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 356:607-609.
9. Van Parijs L., Ibraghimov A., Abbas A.K. (1996) The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity 4:321-328.
10. + T cells do not require costimulation for proliferation and differentiation into cytotoxic effector cells. J Immunol 164:1216-1222.
11. + T cells through transfer of the peptide to T cell MHC molecules. Proc Natl Acad Sci USA 99:13729-13734.
12. Schott E., Bertho N., Ge Q., Maurice M.M., Ploegh H.L. (2002) Class I negative CD8 T cells reveal the confounding role of peptide-transfer onto CD8 T cells stimulated with soluble H2-Kb molecules. Proc Natl Acad Sci USA 99:13735-13740. (Pubitemid 35215450)
13. Mitaksov V., et al. (2007) Structural engineering of pMHC reagents for T cell vaccines and diagnostics. Chem Biol 14:909-922. (Pubitemid 47268780)
14. Yu Y.Y., Netuschil N., Lybarger L., Connolly J.M., Hansen T.H. (2002) Cutting edge: Singlechain trimers of MHC class I molecules form stable structures that potently stimulate antigen-specific T cells and B cells. J Immunol 168:3145-3149. (Pubitemid 34250372)
15. + cytotoxic T cells in the destruction of pancreatic β-cells in nonobese diabetic mice. J Immunol 152:2042-2050.
16. + T cells in NOD mice. Immunol Rev 204:250-263.
17. Lieberman S.M., et al. (2003) Identification of the β cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes. Proc Natl Acad Sci USA 100:8384-8388. (Pubitemid 36842554)
18. Verdaguer J., et al. (1997) Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice. J Exp Med 186:1663-1676. (Pubitemid 27506280)
19. + T cell reactivity to three islet antigens, including the newly identified widely expressed dystrophia myotonica kinase. J Immunol 173:6727-6734.
20. Trudeau J.D., et al. (2003) Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood. J Clin Invest 111:217-223. (Pubitemid 36105920)
21. Jarchum I., Nichol L., Trucco M., Santamaria P., DiLorenzo T.P. (2008) Identification of novel IGRP epitopes targeted in type 1 diabetes patients. Clin Immunol 127:359-365.
22. + T-cell responses identify β-cell autoimmunity in human type 1 diabetes. Diabetes 56:613-621.
23. Standifer N.E., et al. (2006) Identification of Novel HLA-A*0201-restricted epitopes in recent-onset type 1 diabetic subjects and antibody-positive relatives. Diabetes 55: 3061-3067. (Pubitemid 44923643)
24. Wallny H.J., et al. (1992) Identification and quantification of a naturally presented peptide as recognized by cytotoxic T lymphocytes specific for an immunogenic tumor variant. Int Immunol 4:1085-1090.
25. d peptide-binding motif. J Biol Chem 281:10618-10625.
26. Wilson I.A., Fremont D.H. (1993) Structural analysis of MHC class I molecules with bound peptide antigens. Semin Immunol 5:75-80.
27. + T cell response against one peptide/MHC complex in autoimmune diabetes. Proc Natl Acad Sci USA 96:9311-9316.
28. Amrani A., et al. (2001) Expansion of the antigenic repertoire of a single T cell receptor upon T cell activation. J Immunol 167:655-666. (Pubitemid 32660817)
29. Guillaume P., et al. (2003) Soluble major histocompatibility complex-peptide octamers with impaired CD8 binding selectively induce Fas-dependent apoptosis. J Biol Chem 278:4500-4509. (Pubitemid 36800945)
30. Krishnamurthy B., et al. (2008) Autoimmunity to both proinsulin and IGRP is required for diabetes in nonobese diabetic 8.3 TCR transgenic mice. J Immunol 180:4458-4464.
31. Zhang Y., et al. (2002) In situ β cell death promotes priming of diabetogenic CD8 T lymphocytes. J Immunol 168:1466-1472. (Pubitemid 34094520)
32. Podojil J.R., Miller S.D. (2009) Molecular mechanisms of T-cell receptor and costimulatory molecule ligation/blockade in autoimmune disease therapy. Immunol Rev 229:337-355.
33. Schiff M. (2011) Abatacept treatment for rheumatoid arthritis. Rheumatology (Oxford) 50:437-449.
34. Hansen T.H., Connolly J.M., Gould K.G., Fremont D.H. (2010) Basic and translational applications of engineered MHC class I proteins. Trends Immunol 31:363-369.
35. Ishioka G.Y., et al. (1994) Failure to demonstrate long-lived MHC saturation both in vitro and in vivo. Implications for therapeutic potential of MHC-blocking peptides. J Immunol 152:4310-4319. (Pubitemid 24134388)
36. Liu E., et al. (2002) Anti-peptide autoantibodies and fatal anaphylaxis in NOD mice in response to insulin self-peptides B: 9-23 and B: 9-23 and B13-23. J Clin Invest 110:1021-1027.
37. Fife B.T., et al. (2006) Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway. J Exp Med 203:2737-2747. (Pubitemid 44833349)
38. Niens M., et al. (2011) Prevention of "humanized" diabetogenic CD8 T-cell responses in HLA-transgenic NOD mice by a multipeptide coupled-cell approach. Diabetes 60: 1229-1236.
39. Xu X.N., et al. (2001) A novel approach to antigen-specific deletion of CTL with minimal cellular activation using α3 domain mutants of MHC class I/peptide complex. Immunity 14:591-602.
40. Appel H., Seth N.P., Gauthier L., Wucherpfennig K.W.(2001) Anergy induction by dimeric TCR ligands. J Immunol 166:5279-5285. (Pubitemid 32280746)
41. + T cells by a soluble dimeric peptide-MHC class II chimera. Nat Immunol 3:383-391.
42. Masteller E.L., et al. (2003) Peptide-MHC class II dimers as therapeutics to modulate antigen-specific T cell responses in autoimmune diabetes. J Immunol 171:5587-5595. (Pubitemid 37432850)
43. Zuo L., et al. (2002) A single-chain class II MHC-IgG3 fusion protein inhibits autoimmune arthritis by induction of antigen-specific hyporesponsiveness. J Immunol 168:2554-2559. (Pubitemid 34171864)
44. Li L., Yi Z., Wang B., Tisch R. (2009) Suppression of ongoing T cell-mediated autoimmunity by peptide-MHC class II dimer vaccination. J Immunol 183:4809-4816.
45. Tsai S., et al. (2010) Reversal of autoimmunity by boosting memory-like autoregulatory T cells. Immunity 32:568-580.
46. Chaparro R.J., DiLorenzo T.P. (2010) An update on the use of NOD mice to study autoimmune (Type 1) diabetes. Expert Rev Clin Immunol 6:939-955.
47. Graser R.T., et al. (2000) Identification of a CD8 T cell that can independently mediate autoimmune diabetes development in the complete absence of CD4 T cell helper functions. J Immunol 164:3913-3918. (Pubitemid 30169851)
48. + T cells from the islets of NOD mice and their use for the study of autoreactive specificities. J Immunol Methods 339:66-73.